This document discusses gastric carcinoma. It begins by defining gastric carcinoma as a malignant lesion of the stomach. It then discusses the epidemiology and risk factors, noting that incidence is highest in Japan and declining worldwide. Common clinical presentations include dyspepsia, epigastric pain, weight loss, and vomiting. Diagnostic tests include endoscopy with biopsy, which has high accuracy. Staging involves evaluating depth of invasion and lymph node involvement. Treatment options are surgery, chemotherapy, and radiotherapy. Prognosis depends on stage, with early-stage carcinoma having high 5-year survival rates.
The document discusses gastric carcinoma (stomach cancer). It provides details on risk factors, clinical presentation, diagnostic testing including endoscopy, staging, treatment options including surgery, chemotherapy and radiation, complications, and prognostic factors. The highest rates of gastric cancer are seen in Japan, and it is more common in males and older individuals. Infection with H. pylori is a significant risk factor. Endoscopy with biopsy is the gold standard for diagnosis. Treatment depends on staging but may include surgery such as total or subtotal gastrectomy. Prognosis depends on depth of invasion and lymph node involvement.
Gastric cancer forms in the inner lining of the stomach and can grow into a tumor. It is usually diagnosed via endoscopy with biopsy. Staging involves endoscopic ultrasound, CT, PET, and endoscopy to determine if the cancer has spread from the stomach lining to deeper layers or lymph nodes. Treatment of early gastric cancer may involve endoscopic resection but later stages typically require surgical resection of part of the stomach along with nearby lymph nodes. The document provides details on the anatomy, symptoms, risk factors, diagnostic tests, classifications, and surgical treatment approaches for gastric cancer.
The stomach J-shaped. It has two surfaces (the anterior & posterior), two curvatures (the greater & lesser), two orifices (the cardia & pylorus). It has fundus, body and pyloric antrum.
Blood supply
The left gastric artery
Right gastric artery
Right gastro-epiploic artery
Left gastro-epiploic artery
Short gastric arteries
Stomach cancer begins when cancer cells form in the inner lining of your stomach. These cells can grow into a tumor. Also called gastric cancer, the disease usually grows slowly over many years.
It could be:
malignant or benign
primary or secondary
Gastric carcinoma is the second most common cancer-related death worldwide. It typically spreads through direct extension, lymphatics, or hematogenously to distant sites like the liver. Staging involves endoscopy, imaging, and biopsy to determine the depth of invasion and lymph node involvement. Surgery aims to perform a curative resection with negative margins and lymph node dissection, but outcomes remain poor with high rates of recurrence.
A 66-year-old man presented with dysphagia and weight loss. An endoscopy revealed adenocarcinoma of the stomach. Further workup with biopsy and CT scan confirmed moderately differentiated adenocarcinoma. The patient's cancer was staged and treatment options of surgery, chemotherapy, radiation or chemoradiation were discussed. Screening for stomach cancer remains controversial but may be recommended for high-risk groups in areas with high incidence.
Gastric cancer is a common cancer worldwide, with high rates in East Asia and Eastern Europe. Napoleon likely died from a stage IIIA gastric cancer based on historical accounts of his symptoms. For diagnosis, endoscopy with biopsy is needed but endoscopic ultrasound and CT scans can help determine tumor depth and metastasis. Treatment depends on stage - early cancers may be treated with endoscopic resection while later stages typically require surgical resection with chemotherapy sometimes used as adjuvant therapy or for palliation. Prognosis correlates with stage, with 5-year survival rates of 90%, 60%, 30%, 8% for stages I-IV respectively.
This document discusses gastric carcinoma. It begins by defining gastric carcinoma as a malignant lesion of the stomach. It then discusses the epidemiology and risk factors, noting that incidence is highest in Japan and declining worldwide. Common clinical presentations include dyspepsia, epigastric pain, weight loss, and vomiting. Diagnostic tests include endoscopy with biopsy, which has high accuracy. Staging involves evaluating depth of invasion and lymph node involvement. Treatment options are surgery, chemotherapy, and radiotherapy. Prognosis depends on stage, with early-stage carcinoma having high 5-year survival rates.
The document discusses gastric carcinoma (stomach cancer). It provides details on risk factors, clinical presentation, diagnostic testing including endoscopy, staging, treatment options including surgery, chemotherapy and radiation, complications, and prognostic factors. The highest rates of gastric cancer are seen in Japan, and it is more common in males and older individuals. Infection with H. pylori is a significant risk factor. Endoscopy with biopsy is the gold standard for diagnosis. Treatment depends on staging but may include surgery such as total or subtotal gastrectomy. Prognosis depends on depth of invasion and lymph node involvement.
Gastric cancer forms in the inner lining of the stomach and can grow into a tumor. It is usually diagnosed via endoscopy with biopsy. Staging involves endoscopic ultrasound, CT, PET, and endoscopy to determine if the cancer has spread from the stomach lining to deeper layers or lymph nodes. Treatment of early gastric cancer may involve endoscopic resection but later stages typically require surgical resection of part of the stomach along with nearby lymph nodes. The document provides details on the anatomy, symptoms, risk factors, diagnostic tests, classifications, and surgical treatment approaches for gastric cancer.
The stomach J-shaped. It has two surfaces (the anterior & posterior), two curvatures (the greater & lesser), two orifices (the cardia & pylorus). It has fundus, body and pyloric antrum.
Blood supply
The left gastric artery
Right gastric artery
Right gastro-epiploic artery
Left gastro-epiploic artery
Short gastric arteries
Stomach cancer begins when cancer cells form in the inner lining of your stomach. These cells can grow into a tumor. Also called gastric cancer, the disease usually grows slowly over many years.
It could be:
malignant or benign
primary or secondary
Gastric carcinoma is the second most common cancer-related death worldwide. It typically spreads through direct extension, lymphatics, or hematogenously to distant sites like the liver. Staging involves endoscopy, imaging, and biopsy to determine the depth of invasion and lymph node involvement. Surgery aims to perform a curative resection with negative margins and lymph node dissection, but outcomes remain poor with high rates of recurrence.
A 66-year-old man presented with dysphagia and weight loss. An endoscopy revealed adenocarcinoma of the stomach. Further workup with biopsy and CT scan confirmed moderately differentiated adenocarcinoma. The patient's cancer was staged and treatment options of surgery, chemotherapy, radiation or chemoradiation were discussed. Screening for stomach cancer remains controversial but may be recommended for high-risk groups in areas with high incidence.
Gastric cancer is a common cancer worldwide, with high rates in East Asia and Eastern Europe. Napoleon likely died from a stage IIIA gastric cancer based on historical accounts of his symptoms. For diagnosis, endoscopy with biopsy is needed but endoscopic ultrasound and CT scans can help determine tumor depth and metastasis. Treatment depends on stage - early cancers may be treated with endoscopic resection while later stages typically require surgical resection with chemotherapy sometimes used as adjuvant therapy or for palliation. Prognosis correlates with stage, with 5-year survival rates of 90%, 60%, 30%, 8% for stages I-IV respectively.
Gastric cancer is a common cancer worldwide, with high rates in East Asia and Eastern Europe. Napoleon likely died from a stage IIIA gastric cancer based on historical accounts of his symptoms. For diagnosis, endoscopy with biopsy is needed but endoscopic ultrasound and CT scans can help determine tumor depth and metastasis. Treatment depends on stage - early cancers may be treated with endoscopic resection while later stages typically require surgical resection with chemotherapy sometimes used as adjuvant therapy or for palliation. Prognosis correlates with stage, with 5-year survival rates of 90%, 60%, 30%, 8% for stages I to IV respectively.
1) Gastric carcinoma is the third leading cause of cancer death worldwide, with highest incidence in East Asia and parts of South America.
2) Risk factors include H. pylori infection, smoking, diet high in salted/preserved foods, and family history of gastric cancer.
3) Early detection through endoscopy in dyspeptic patients over 50 years old or with red flags can improve outcomes, as resection allows for potential cure in early gastric cancer confined to mucosa or submucosa.
Gastric carcinoma is the 4th most common cancer and the second leading cause of cancer death globally. It occurs most commonly in individuals aged 50-70 years and is more prevalent in males. Risk factors include H. pylori infection, smoking, and low socioeconomic status. Genetic factors like E-cadherin mutations also increase risk. Staging involves endoscopy with biopsy, endoscopic ultrasound, CT, and diagnostic laparoscopy. Treatment depends on stage but may include endoscopic resection for early cancer or gastrectomy with lymph node dissection for more advanced disease. Post-operative complications can include dumping syndrome, nutritional deficiencies, or bowel obstructions.
Colorectal cancer is the third most common cancer in the United States. The risk increases with age, with over 90% of cases being diagnosed in patients over 50 years old. Colorectal cancer can develop from pre-cancerous polyps through a process known as the adenoma-carcinoma sequence. Genetic and environmental factors can contribute to the development of colorectal cancer. Staging systems such as Dukes staging and TNM staging are used to determine the prognosis and appropriate treatment.
The document discusses tumors of the small and large intestines. It classifies intestinal tumors and provides details on various benign and malignant tumor types. The most common tumors are epithelial tumors, with colorectal cancer representing 70% of all gastrointestinal malignancies. Adenomas are precursors to most colorectal cancers. Risk factors include inflammatory bowel disease, familial polyposis, and diet. Prognosis and treatment depend on tumor stage and characteristics.
1. Colorectal cancer is the third most common malignancy worldwide, with over 1.2 million new cases annually. The risk increases with age, with most cases occurring after age 50.
2. Screening is recommended for average risk individuals starting at age 50, and earlier for those with risk factors like family history or inflammatory bowel disease. Screening options include annual fecal tests and colonoscopy every 10 years.
3. Treatment depends on the cancer stage and location. Early stage cancers are typically treated with surgery alone, while later stages may involve chemotherapy and radiation in addition to surgery. The goals are curative therapy for early stages and palliative care for metastatic disease.
This document discusses gastric cancer, including its incidence, risk factors, pathogenesis, clinical presentation, diagnostic evaluation, staging, and treatment approaches. Some key points include:
- Gastric cancer has a poor prognosis with only 20% 5-year survival. Early diagnosis is key.
- Risk factors include H. pylori infection, smoking, low socioeconomic status, and diets high in salt/preserved foods.
- Diagnosis involves endoscopy with biopsy. Staging evaluates tumor invasion and metastasis using CT, PET, and laparoscopy.
- Surgery offering total or subtotal gastrectomy is the only curative option, while chemotherapy and radiation are palliative.
This document provides information on carcinoma of the stomach, including:
- Risk factors include H. pylori infection, diet, genetics, smoking.
- Types include intestinal and diffuse. Staging uses TNM and other classifications.
- Common symptoms are weight loss, abdominal pain, vomiting. Investigations include endoscopy and biopsy.
- Treatment depends on stage but commonly includes surgery such as gastrectomy along with lymph node dissection. Endoscopic resection may be used for early stages. Adjuvant therapy is sometimes used for later stages.
Gastric carcinoma is the fourth most common cancer worldwide and the second leading cause of cancer death globally. It has a poor prognosis except in areas that conduct early screening. Approximately 95% are adenocarcinomas. Risk factors include H. pylori infection, smoking, genetic factors, and precancerous lesions. Staging involves endoscopy, CT, PET, and laparoscopy. Surgery with curative intent plus perioperative chemotherapy may cure early stage tumors. Advanced or metastatic disease is treated with palliative chemotherapy, radiation or surgery.
This document discusses malignant neoplasms of the stomach. Some key points:
- Stomach cancer is the 5th most common cancer globally and the 3rd leading cause of cancer death. Outcomes are generally poor due to late stage at presentation.
- Risk factors include H. pylori infection, smoking, low fruit/vegetable diet, family history, and prior gastric surgery or conditions like pernicious anemia.
- Tumors are classified by location, histology (intestinal vs diffuse), and stage. Diagnosis involves endoscopy, biopsy, and imaging.
- Treatment depends on stage but commonly includes surgical resection with lymph node dissection, with or without adjuvant chemotherapy/radiation
This document discusses tumors of the small and large intestines. It begins by describing non-neoplastic polyps such as hyperplastic, hamartomatous, inflammatory, and lymphoid polyps. It then discusses neoplastic epithelial lesions including benign adenomas and malignant adenocarcinoma, carcinoid tumors, squamous cell carcinoma, and malignant melanoma. Mesenchymal lesions such as gastrointestinal stromal tumor (GIST) and lymphoma are also reviewed. Specific topics covered in more depth include familial adenomatous polyposis, the adenoma-carcinoma sequence in colorectal carcinoma development, carcinoid tumors, gastrointestinal lymphoma, and TNM staging of colorectal carcinomas
The document discusses the anatomy, histology, physiology, carcinogenesis, clinical presentation, diagnosis, staging, and treatment of gastric cancer. It notes that gastric cancer typically presents with nonspecific symptoms like abdominal pain or weight loss. Diagnosis involves endoscopy with biopsy. Staging involves endoscopic ultrasound or CT scan to evaluate tumor invasion and lymph node involvement. Treatment depends on stage but may include surgery, chemotherapy, and radiation. Screening high-risk individuals can detect early gastric cancer and improve outcomes.
A 30-year-old female presented with a one month history of left iliac fossa pain, anorexia, weight loss, and vomiting for one week. Examination revealed a tender palpable mass in the left iliac fossa. CT scan showed sigmoid colon cancer with liver metastases. At laparotomy, a perforated sigmoid colon mass was found adhered to surrounding structures with pus collection. A sigmoid colectomy with end colostomy was performed.
The document summarizes key anatomical and clinical aspects of the rectum:
1. The rectum is 12-15 cm long, located in the pelvis behind the lower sacrum and coccyx. It has three sections with varying peritoneal coverage and blood supply.
2. Rectal cancer is the third most common cancer in the US. Risk factors include diet, family history, and conditions like ulcerative colitis. Symptoms often include changes in bowel habits or bleeding.
3. Treatment involves surgery like low anterior resection or abdominoperineal resection. Total mesorectal excision improves outcomes by completely removing the mesorectum and reducing local recurrence rates.
Pancreatic cancer arises from uncontrolled growth of cells in the pancreas. It most often develops in the exocrine tissues and is typically diagnosed in individuals aged 60-80 years. Risk factors include smoking, chronic pancreatitis, obesity, and certain genetic syndromes. Symptoms are often vague in early stages but may include weight loss, abdominal pain, and jaundice. Diagnosis involves blood tests, abdominal imaging like ultrasound or CT scan, and biopsy. Staging evaluates tumor size and spread. Treatment options include surgery, chemotherapy, radiation, and pain management. Prognosis is generally poor with only 10% of patients surviving more than 5 years.
1) The stomach is located in the abdomen between the esophagus and small intestine. It has five regions and receives blood supply from branches of the celiac trunk and superior mesenteric artery.
2) Gastric cancer is usually adenocarcinoma. Risk factors include H. pylori infection, smoking, and family history. Symptoms include dyspepsia, weight loss, and vomiting.
3) Diagnosis involves endoscopy with biopsy. Treatment depends on stage but may include endoscopic resection for early cancer, surgery such as total gastrectomy with lymph node dissection, or chemotherapy and radiation.
Colorectal cancer is the third most commonly diagnosed cancer worldwide. Risk factors include increasing age, family history, inflammatory bowel disease, lifestyle factors like obesity and smoking. Screening is recommended regularly beginning at age 50 to detect cancers early. Staging uses the TNM system and treatment depends on stage but commonly includes surgery along with chemotherapy and radiation for later stages. The document provides detailed information on epidemiology, risk factors, stages, diagnosis, treatment and screening guidelines for colorectal cancer.
This document discusses malignant obstructive jaundice and its causes such as gallbladder cancer and bile duct cancer. It provides details on the incidence, risk factors, pathology, staging, clinical presentation, diagnosis, and management of gallbladder cancer. Key points include that gallbladder cancer occurs predominantly in elderly people, has a poor prognosis, and is often diagnosed at late stages. Surgical resection is the main treatment for early stage disease while palliative options are used for advanced or unresectable cases. Prognosis depends on the pathologic stage, with T1a cancers having an excellent prognosis.
Gastric cancer is a common cancer worldwide, with high rates in East Asia and Eastern Europe. Napoleon likely died from a stage IIIA gastric cancer based on historical accounts of his symptoms. For diagnosis, endoscopy with biopsy is needed but endoscopic ultrasound and CT scans can help determine tumor depth and metastasis. Treatment depends on stage - early cancers may be treated with endoscopic resection while later stages typically require surgical resection with chemotherapy sometimes used as adjuvant therapy or for palliation. Prognosis correlates with stage, with 5-year survival rates of 90%, 60%, 30%, 8% for stages I to IV respectively.
1) Gastric carcinoma is the third leading cause of cancer death worldwide, with highest incidence in East Asia and parts of South America.
2) Risk factors include H. pylori infection, smoking, diet high in salted/preserved foods, and family history of gastric cancer.
3) Early detection through endoscopy in dyspeptic patients over 50 years old or with red flags can improve outcomes, as resection allows for potential cure in early gastric cancer confined to mucosa or submucosa.
Gastric carcinoma is the 4th most common cancer and the second leading cause of cancer death globally. It occurs most commonly in individuals aged 50-70 years and is more prevalent in males. Risk factors include H. pylori infection, smoking, and low socioeconomic status. Genetic factors like E-cadherin mutations also increase risk. Staging involves endoscopy with biopsy, endoscopic ultrasound, CT, and diagnostic laparoscopy. Treatment depends on stage but may include endoscopic resection for early cancer or gastrectomy with lymph node dissection for more advanced disease. Post-operative complications can include dumping syndrome, nutritional deficiencies, or bowel obstructions.
Colorectal cancer is the third most common cancer in the United States. The risk increases with age, with over 90% of cases being diagnosed in patients over 50 years old. Colorectal cancer can develop from pre-cancerous polyps through a process known as the adenoma-carcinoma sequence. Genetic and environmental factors can contribute to the development of colorectal cancer. Staging systems such as Dukes staging and TNM staging are used to determine the prognosis and appropriate treatment.
The document discusses tumors of the small and large intestines. It classifies intestinal tumors and provides details on various benign and malignant tumor types. The most common tumors are epithelial tumors, with colorectal cancer representing 70% of all gastrointestinal malignancies. Adenomas are precursors to most colorectal cancers. Risk factors include inflammatory bowel disease, familial polyposis, and diet. Prognosis and treatment depend on tumor stage and characteristics.
1. Colorectal cancer is the third most common malignancy worldwide, with over 1.2 million new cases annually. The risk increases with age, with most cases occurring after age 50.
2. Screening is recommended for average risk individuals starting at age 50, and earlier for those with risk factors like family history or inflammatory bowel disease. Screening options include annual fecal tests and colonoscopy every 10 years.
3. Treatment depends on the cancer stage and location. Early stage cancers are typically treated with surgery alone, while later stages may involve chemotherapy and radiation in addition to surgery. The goals are curative therapy for early stages and palliative care for metastatic disease.
This document discusses gastric cancer, including its incidence, risk factors, pathogenesis, clinical presentation, diagnostic evaluation, staging, and treatment approaches. Some key points include:
- Gastric cancer has a poor prognosis with only 20% 5-year survival. Early diagnosis is key.
- Risk factors include H. pylori infection, smoking, low socioeconomic status, and diets high in salt/preserved foods.
- Diagnosis involves endoscopy with biopsy. Staging evaluates tumor invasion and metastasis using CT, PET, and laparoscopy.
- Surgery offering total or subtotal gastrectomy is the only curative option, while chemotherapy and radiation are palliative.
This document provides information on carcinoma of the stomach, including:
- Risk factors include H. pylori infection, diet, genetics, smoking.
- Types include intestinal and diffuse. Staging uses TNM and other classifications.
- Common symptoms are weight loss, abdominal pain, vomiting. Investigations include endoscopy and biopsy.
- Treatment depends on stage but commonly includes surgery such as gastrectomy along with lymph node dissection. Endoscopic resection may be used for early stages. Adjuvant therapy is sometimes used for later stages.
Gastric carcinoma is the fourth most common cancer worldwide and the second leading cause of cancer death globally. It has a poor prognosis except in areas that conduct early screening. Approximately 95% are adenocarcinomas. Risk factors include H. pylori infection, smoking, genetic factors, and precancerous lesions. Staging involves endoscopy, CT, PET, and laparoscopy. Surgery with curative intent plus perioperative chemotherapy may cure early stage tumors. Advanced or metastatic disease is treated with palliative chemotherapy, radiation or surgery.
This document discusses malignant neoplasms of the stomach. Some key points:
- Stomach cancer is the 5th most common cancer globally and the 3rd leading cause of cancer death. Outcomes are generally poor due to late stage at presentation.
- Risk factors include H. pylori infection, smoking, low fruit/vegetable diet, family history, and prior gastric surgery or conditions like pernicious anemia.
- Tumors are classified by location, histology (intestinal vs diffuse), and stage. Diagnosis involves endoscopy, biopsy, and imaging.
- Treatment depends on stage but commonly includes surgical resection with lymph node dissection, with or without adjuvant chemotherapy/radiation
This document discusses tumors of the small and large intestines. It begins by describing non-neoplastic polyps such as hyperplastic, hamartomatous, inflammatory, and lymphoid polyps. It then discusses neoplastic epithelial lesions including benign adenomas and malignant adenocarcinoma, carcinoid tumors, squamous cell carcinoma, and malignant melanoma. Mesenchymal lesions such as gastrointestinal stromal tumor (GIST) and lymphoma are also reviewed. Specific topics covered in more depth include familial adenomatous polyposis, the adenoma-carcinoma sequence in colorectal carcinoma development, carcinoid tumors, gastrointestinal lymphoma, and TNM staging of colorectal carcinomas
The document discusses the anatomy, histology, physiology, carcinogenesis, clinical presentation, diagnosis, staging, and treatment of gastric cancer. It notes that gastric cancer typically presents with nonspecific symptoms like abdominal pain or weight loss. Diagnosis involves endoscopy with biopsy. Staging involves endoscopic ultrasound or CT scan to evaluate tumor invasion and lymph node involvement. Treatment depends on stage but may include surgery, chemotherapy, and radiation. Screening high-risk individuals can detect early gastric cancer and improve outcomes.
A 30-year-old female presented with a one month history of left iliac fossa pain, anorexia, weight loss, and vomiting for one week. Examination revealed a tender palpable mass in the left iliac fossa. CT scan showed sigmoid colon cancer with liver metastases. At laparotomy, a perforated sigmoid colon mass was found adhered to surrounding structures with pus collection. A sigmoid colectomy with end colostomy was performed.
The document summarizes key anatomical and clinical aspects of the rectum:
1. The rectum is 12-15 cm long, located in the pelvis behind the lower sacrum and coccyx. It has three sections with varying peritoneal coverage and blood supply.
2. Rectal cancer is the third most common cancer in the US. Risk factors include diet, family history, and conditions like ulcerative colitis. Symptoms often include changes in bowel habits or bleeding.
3. Treatment involves surgery like low anterior resection or abdominoperineal resection. Total mesorectal excision improves outcomes by completely removing the mesorectum and reducing local recurrence rates.
Pancreatic cancer arises from uncontrolled growth of cells in the pancreas. It most often develops in the exocrine tissues and is typically diagnosed in individuals aged 60-80 years. Risk factors include smoking, chronic pancreatitis, obesity, and certain genetic syndromes. Symptoms are often vague in early stages but may include weight loss, abdominal pain, and jaundice. Diagnosis involves blood tests, abdominal imaging like ultrasound or CT scan, and biopsy. Staging evaluates tumor size and spread. Treatment options include surgery, chemotherapy, radiation, and pain management. Prognosis is generally poor with only 10% of patients surviving more than 5 years.
1) The stomach is located in the abdomen between the esophagus and small intestine. It has five regions and receives blood supply from branches of the celiac trunk and superior mesenteric artery.
2) Gastric cancer is usually adenocarcinoma. Risk factors include H. pylori infection, smoking, and family history. Symptoms include dyspepsia, weight loss, and vomiting.
3) Diagnosis involves endoscopy with biopsy. Treatment depends on stage but may include endoscopic resection for early cancer, surgery such as total gastrectomy with lymph node dissection, or chemotherapy and radiation.
Colorectal cancer is the third most commonly diagnosed cancer worldwide. Risk factors include increasing age, family history, inflammatory bowel disease, lifestyle factors like obesity and smoking. Screening is recommended regularly beginning at age 50 to detect cancers early. Staging uses the TNM system and treatment depends on stage but commonly includes surgery along with chemotherapy and radiation for later stages. The document provides detailed information on epidemiology, risk factors, stages, diagnosis, treatment and screening guidelines for colorectal cancer.
This document discusses malignant obstructive jaundice and its causes such as gallbladder cancer and bile duct cancer. It provides details on the incidence, risk factors, pathology, staging, clinical presentation, diagnosis, and management of gallbladder cancer. Key points include that gallbladder cancer occurs predominantly in elderly people, has a poor prognosis, and is often diagnosed at late stages. Surgical resection is the main treatment for early stage disease while palliative options are used for advanced or unresectable cases. Prognosis depends on the pathologic stage, with T1a cancers having an excellent prognosis.
Similar to Benign & Malignant Tumors of the Stomach (20)
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)MuskanShingari
Statistics- Statistics is the science of collecting, organizing, presenting, analyzing and interpreting numerical data to assist in making more effective decisions.
A statistics is a measure which is used to estimate the population parameter
Parameters-It is used to describe the properties of an entire population.
Examples-Measures of central tendency Dispersion, Variance, Standard Deviation (SD), Absolute Error, Mean Absolute Error (MAE), Eigen Value
Congestive Heart failure is caused by low cardiac output and high sympathetic discharge. Diuretics reduce preload, ACE inhibitors lower afterload, beta blockers reduce sympathetic activity, and digitalis has inotropic effects. Newer medications target vasodilation and myosin activation to improve heart efficiency while lowering energy requirements. Combination therapy, following an assessment of cardiac function and volume status, is the most effective strategy to heart failure care.
Selective alpha1 blockers are Prazosin, Terazosin, Doxazosin, Tamsulosin and Silodosin majorly used to treat BPH, also hypertension, PTSD, Raynaud's phenomenon, CHF
Gene therapy can be broadly defined as the transfer of genetic material to cure a disease or at least to improve the clinical status of a patient.
One of the basic concepts of gene therapy is to transform viruses into genetic shuttles, which will deliver the gene of interest into the target cells.
Safe methods have been devised to do this, using several viral and non-viral vectors.
In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
The biggest hurdle faced by medical research in gene therapy is the availability of effective gene-carrying vectors that meet all of the following criteria:
Protection of transgene or genetic cargo from degradative action of systemic and endonucleases,
Delivery of genetic material to the target site, i.e., either cell cytoplasm or nucleus,
Low potential of triggering unwanted immune responses or genotoxicity,
Economical and feasible availability for patients .
Viruses are naturally evolved vehicles that efficiently transfer their genes into host cells.
Choice of viral vector is dependent on gene transfer efficiency, capacity to carry foreign genes, toxicity, stability, immune responses towards viral antigens and potential viral recombination.
There are a wide variety of vectors used to deliver DNA or oligo nucleotides into mammalian cells, either in vitro or in vivo.
The most common vector system based on retroviruses, adenoviruses, herpes simplex viruses, adeno associated viruses.
Pictorial and detailed description of patellar instability with sign and symptoms and how to diagnose , what investigations you should go with and how to approach with treatment options . I have presented this slide in my 2nd year junior residency in orthopedics at LLRM medical college Meerut and got good reviews for it
After getting it read you will definitely understand the topic.
“Environmental sanitation means the art and science of applying sanitary, biological and physical science principles and knowledge to improve and control the environment therein for the protection of the health and welfare of the public”.The overall importance of sanitation are to provide a healthy living environment for everyone, to protect the natural resources (such as surface water, groundwater, soil ), and to provide safety, security and dignity for people when they defecate or urinate .Sanitation refers to public health conditions such as drinking clean water, sewage treatment, etc. All the effective tools and actions that help in keeping the environment clean come under sanitation. Sanitation refers to public health conditions such as drinking clean water, sewage treatment. All the effective tools and actions that help in keeping the environment clean and promotes public health is the necessary in todays life.
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdfOsvaldo Bernardo Muchanga
GASTROINTESTINAL INFECTIONS AND GASTRITIS
Osvaldo Bernardo Muchanga
Gastrointestinal Infections
GASTROINTESTINAL INFECTIONS result from the ingestion of pathogens that cause infections at the level of this tract, generally being transmitted by food, water and hands contaminated by microorganisms such as E. coli, Salmonella, Shigella, Vibrio cholerae, Campylobacter, Staphylococcus, Rotavirus among others that are generally contained in feces, thus configuring a FECAL-ORAL type of transmission.
Among the factors that lead to the occurrence of gastrointestinal infections are the hygienic and sanitary deficiencies that characterize our markets and other places where raw or cooked food is sold, poor environmental sanitation in communities, deficiencies in water treatment (or in the process of its plumbing), risky hygienic-sanitary habits (not washing hands after major and/or minor needs), among others.
These are generally consequences (signs and symptoms) resulting from gastrointestinal infections: diarrhea, vomiting, fever and malaise, among others.
The treatment consists of replacing lost liquids and electrolytes (drinking drinking water and other recommended liquids, including consumption of juicy fruits such as papayas, apples, pears, among others that contain water in their composition).
To prevent this, it is necessary to promote health education, improve the hygienic-sanitary conditions of markets and communities in general as a way of promoting, preserving and prolonging PUBLIC HEALTH.
Gastritis and Gastric Health
Gastric Health is one of the most relevant concerns in human health, with gastrointestinal infections being among the main illnesses that affect humans.
Among gastric problems, we have GASTRITIS AND GASTRIC ULCERS as the main public health problems. Gastritis and gastric ulcers normally result from inflammation and corrosion of the walls of the stomach (gastric mucosa) and are generally associated (caused) by the bacterium Helicobacter pylor, which, according to the literature, this bacterium settles on these walls (of the stomach) and starts to release urease that ends up altering the normal pH of the stomach (acid), which leads to inflammation and corrosion of the mucous membranes and consequent gastritis or ulcers, respectively.
In addition to bacterial infections, gastritis and gastric ulcers are associated with several factors, with emphasis on prolonged fasting, chemical substances including drugs, alcohol, foods with strong seasonings including chilli, which ends up causing inflammation of the stomach walls and/or corrosion. of the same, resulting in the appearance of wounds and consequent gastritis or ulcers, respectively.
Among patients with gastritis and/or ulcers, one of the dilemmas is associated with the foods to consume in order to minimize the sensation of pain and discomfort.
Breast cancer: Post menopausal endocrine therapyDr. Sumit KUMAR
Breast cancer in postmenopausal women with hormone receptor-positive (HR+) status is a common and complex condition that necessitates a multifaceted approach to management. HR+ breast cancer means that the cancer cells grow in response to hormones such as estrogen and progesterone. This subtype is prevalent among postmenopausal women and typically exhibits a more indolent course compared to other forms of breast cancer, which allows for a variety of treatment options.
Diagnosis and Staging
The diagnosis of HR+ breast cancer begins with clinical evaluation, imaging, and biopsy. Imaging modalities such as mammography, ultrasound, and MRI help in assessing the extent of the disease. Histopathological examination and immunohistochemical staining of the biopsy sample confirm the diagnosis and hormone receptor status by identifying the presence of estrogen receptors (ER) and progesterone receptors (PR) on the tumor cells.
Staging involves determining the size of the tumor (T), the involvement of regional lymph nodes (N), and the presence of distant metastasis (M). The American Joint Committee on Cancer (AJCC) staging system is commonly used. Accurate staging is critical as it guides treatment decisions.
Treatment Options
Endocrine Therapy
Endocrine therapy is the cornerstone of treatment for HR+ breast cancer in postmenopausal women. The primary goal is to reduce the levels of estrogen or block its effects on cancer cells. Commonly used agents include:
Selective Estrogen Receptor Modulators (SERMs): Tamoxifen is a SERM that binds to estrogen receptors, blocking estrogen from stimulating breast cancer cells. It is effective but may have side effects such as increased risk of endometrial cancer and thromboembolic events.
Aromatase Inhibitors (AIs): These drugs, including anastrozole, letrozole, and exemestane, lower estrogen levels by inhibiting the aromatase enzyme, which converts androgens to estrogen in peripheral tissues. AIs are generally preferred in postmenopausal women due to their efficacy and safety profile compared to tamoxifen.
Selective Estrogen Receptor Downregulators (SERDs): Fulvestrant is a SERD that degrades estrogen receptors and is used in cases where resistance to other endocrine therapies develops.
Combination Therapies
Combining endocrine therapy with other treatments enhances efficacy. Examples include:
Endocrine Therapy with CDK4/6 Inhibitors: Palbociclib, ribociclib, and abemaciclib are CDK4/6 inhibitors that, when combined with endocrine therapy, significantly improve progression-free survival in advanced HR+ breast cancer.
Endocrine Therapy with mTOR Inhibitors: Everolimus, an mTOR inhibitor, can be added to endocrine therapy for patients who have developed resistance to aromatase inhibitors.
Chemotherapy
Chemotherapy is generally reserved for patients with high-risk features, such as large tumor size, high-grade histology, or extensive lymph node involvement. Regimens often include anthracyclines and taxanes.
Spontaneous Bacterial Peritonitis - Pathogenesis , Clinical Features & Manage...Jim Jacob Roy
In this presentation , SBP ( spontaneous bacterial peritonitis ) , which is a common complication in patients with cirrhosis and ascites is described in detail.
The reference for this presentation is Sleisenger and Fordtran's Gastrointestinal and Liver Disease Textbook ( 11th edition ).
PGx Analysis in VarSeq: A User’s PerspectiveGolden Helix
Since our release of the PGx capabilities in VarSeq, we’ve had a few months to gather some insights from various use cases. Some users approach PGx workflows by means of array genotyping or what seems to be a growing trend of adding the star allele calling to the existing NGS pipeline for whole genome data. Luckily, both approaches are supported with the VarSeq software platform. The genotyping method being used will also dictate what the scope of the tertiary analysis will be. For example, are your PGx reports a standalone pipeline or would your lab’s goal be to handle a dual-purpose workflow and report on PGx + Diagnostic findings.
The purpose of this webcast is to:
Discuss and demonstrate the approaches with array and NGS genotyping methods for star allele calling to prep for downstream analysis.
Following genotyping, explore alternative tertiary workflow concepts in VarSeq to handle PGx reporting.
Moreover, we will include insights users will need to consider when validating their PGx workflow for all possible star alleles and options you have for automating your PGx analysis for large number of samples. Please join us for a session dedicated to the application of star allele genotyping and subsequent PGx workflows in our VarSeq software.
BBB and BCF
control the entry of compounds into the brain and
regulate brain homeostasis.
restricts access to brain cells of blood–borne compounds and
facilitates nutrients essential for normal metabolism to reach brain cells
4. Gastric Carcinoma
55 year old Japanese male who is living in
Japan & working in industry.
DEFINITION Malignant lesion of the stomach.
Epidemiology & Risk Factors
Can occur at any age
But Peak incidece
Is 50-70 years old.
It is more aggressive
In younger ages.
Japan has the world
highest Rate of
gastric cancer.
Studies have confirmed
that incidence decline in
Japanese immigrant to
America.
dust ingestion
from a variety
of industrial
processes
may be a risk.
Twise more common
In male than in female
Incidence of Gastric Carcinoma:
Japan 70 in100,000/year
Europe 40 in 100,000/year
UK 15 in 100,000/year
USA 10 in 100,000/year
It is decreasing worldwide.
6. Clinical Presentation
Most patients present with advanced stage..
why?
They are often asymptomatic in early stages.
Common clinical Presentation:
The patient complained of loss of appetite that was
followed by weight loss of 10Kg in 4 weeks.
He had notice
epigastric discomfort & postprandial fullness.
He presented to the ER complaining of vomiting of
large quantities of undigested food & epigastric
distension.
Dyspepsia
epigastric pain
Bloating
early satiety
nausea & vomiting*
dysphagia*
anorexia
weight loss
upper GI bleeding
(hematemesis, melena,
iron deficiency anemia)
8. Pathology
DIO Classification
Lauren Classification:
1. Intestinal Gastric ca.
It arises in areas of intestinal metaplasia to form
polypoid tumors or ulcers.
2. Diffuse Gastric ca.
It infiltrates deeply in the stomach without
forming obvious mass lesions but spreads widely in
the gastric wall “Linitis Plastica”
& it has much more worse prognosis
3. Mixed Morphology.
10. Gastric cancer can be devided into:
Early:
Limited to mucosa & submucosa with or without
LN (T1, any N)
>> curable with 5 years survival rate in 90%.
Advanced:
It involves the Muscularis.
It has 4 types( Bormann’s classification). Type III
& IV are incurable.
11. T1 lamina propria & submucosa
T2 muscularis & subserosa
T3 serosa
T4 Adjacent organs
N0 no lymph node
N1 Epigastric node
N2 main arterial trunk
M0 No distal metastasis
M1 distal metastasis
Staging of gastric cancer
Spread of Gastric Cancer
Direct Spread
Blood-borne
metastasis
Lymphatic spread
Transperitoneal
spread
Tumor penetrates the
muscularis, serosa &
Adjacent organs
(Pancreas,colon &liver)
What is important here is
Virchow’s node
(Trosier’s sign)
Usually with extensive
Disease where liver 1st
Involved then lung &
Bone
This is common
Anywhere in peritoneal cavity
(Ascitis)
Krukenberg tumor (ovaries)
Sister Joseph nodule
(umbilicus)
12. Complications
Peritoneal and pleural effusion
Obstruction of gastric outlet or small bowel
Bleeding
Intrahepatc jaundice by hepatomegaly
13. Differential Diagnosis
1.Gastric ulcer
2.Other gastric neoplasms
3.Gastritis
4.Gastric Polyp
5.Crohns disease.
From history,
Cancer is not relieved by antacids
Not periodic
Not releived by eating or vomiting.
14. INVESTIGATIONS
Full blood count –IDA-
LFT,RFT
Amylase & lipase.
Serum tumor markers (CA 72-4,CEA,CA19-
9) not specific
Stool examination for occult blood
CXR ,Bone scan.
16. EGD esophagogastroduodenoscopy
Diagnostic accuracy is 98%
if upto 7 biopsies is taken.
Double Contrast barium upper GI x-ray
Diagnostic accuracy 90%
WHY?
Diagnostic study of Choice
1.Early superficial gastric mucosal lesion
can be missed.
2. can’t differentiate b/w benign ulcer &
Ulcerating adenocarcinoma.
17. X-ray showing Gastric ulcer
With symmetrical radiating
Mucosal folds.
By histology, no evidence of
Malignancies was observed.
X-ray showing Extensive
carcinoma involving
the cardia & Fundus
Pyloric stenosis
18. CT,MRI & US:
Laparoscopy:
Help in assessment of wall thickness,
metastases (peritoneum ,liver & LNs)
Detection of peritoneal
metastases
19.
20. THE GOLD STANDARD
It allows taking biopsies
Safe (in experienced hands)
UGI ENDOSCOPY
21.
22. UGI ENDOSCOPY,contd.
You may see an ulcer (25%),
polypoid mass (25%), superficial
spreading (10%),or infiltrative
(linnitis plastica)-difficult to be
detected-
Accuracy 50-95% it depends on
gross appearance,size,location &
no. of biopsies
23. IF YOU SEE ULCER ASK UR
SELF…BENIGN OR MALIGNANT?
MALIGNANT
BENIGN
Irregular outline with
necrotic or hemorrhagic
base
Round to oval punched out
lesion with straight walls &
flat smooth base
Irregular & raised margins
Smooth margins with
normal surrounding
mucosa
Anywhere
Mostly on lesser curvature
Any size
Majority<2cm
Prominent & edematous
rugal folds that usually do
not extend to the margins
Normal adjoining rugal
folds that extend to the
margins of the base
26. Treatment
Initial treatment:
1.Improve nutrition if
needed by parentral
or enteral feeding.
2.Correct fluid
&electrolyte
& anemia if they are
present.
Preoperative Care
Preoperative Staging is
important because we
don’t want to subject
the patient to radical
surgery that can’t help
him.
27. PRE-OPERATIVE CARE
Careful preoperative staging
Screen for any nutritional deficiencies
& consider nutritional support
Symptomatic control
Blood transfusion in symptomatic
anemia
Hydration
Prophylactic antibiotics
ABO & crossmatch
Ask about current medications &
allergies
Cessation of smoking
29. TOTAL (RADICAL) GASTRECTOMY
o Remove the stomach +distal part
of esophagus+ proximal part of
dudenum + greater & lesser
omenta + LNs
o Oesophagojejunostomy with roux-
en-y .
30.
31. SUBTOTAL GASTRECTOMY
Similar to total one except that the
PROXIMAL PART of the stomach
is preserved
Followed by reconstruction &
creating anastomosis
( by gastrojejunostomy,billroth II )
32. PALLIATIVE SURGERY
• For pts with advanced (inoperable)
disease & suffering significant
symptoms e.g. obstruction,
bleeding.
• Palliative gastrectomy not
necessarily to be radical, remove
resectable masses & reconstruct
(anastomosis/intubation/stenting/
recanalisation)
35. 2.Chemotherapy:
Responds well, but there is no effect on servival.
Marsden Regimen
Epirubicin, cisplatin &5-flurouracil (3 wks)
6 cycles
Response rate : 40% .
3. Radiotherapy:
Postperative-radiotherpy: may decrease the
recurrence.
36. Preventive measures
By diet
Convincing:
vegetable & fruits.
Probable:
Vit.C &E
Possible
Carotenoids,whole grean cereals and
green tea.
Smoking cessation
Cessation of alcohol intake
Early diagnosis remains the Key
Problem
37. PROGNOSTIC FEATURES
2 important factors influencing survival in
resectable gastric cancer:
depth of cancer invasion
presence or absence of regional LN
involvement
• 5yrs survival rate:
10% in USA
50% in Japan
38.
39. Gastrointestinal Stromal Tumor
‘GIST’
Previously leiomyoma & leomyosarcoma.
<1 %
Rarly cause bleeding or obstruction.
The origion: Intestinal Cells of Cajal ‘ICC;s’
autonomic nervous system.
The distinction bw benign & malignant is
unclear. In general terms, the larger the
tumor & greater mitotic activity, the more
likely to metastases.
The stomach is the most common site of
GIST.
40. Usually are discovered incidentally on
endoscopy or barium meal
The endoscopic biopsies may be
uninformative bcz the overlying mucosa is
usually normal
Small tumorswedge resection
Larger onesgastrectomy
41.
42. Gastric Lymphoma
Most common primary GI Lymphoma .
It’s increasing in frequency.
Presentation:
Similar to gastric carcinoma.
May reveal peripheral adenopathy,
abdominal mass or spleenomegaly.
43. Diagnosis:
1.EGD 2.contrast GI x-ray.
3.CT guided fine needle biopsy.
Treatment :
1. surgery: total or subtotal gastrectomy
with spleenectomy or palliative
resection.
2.Adjunct radiotherapy: may improve 5
year survival
3.Adjunct Chemotherapy: may prevent
recurrance.
44. E-medicine web site
The Washington Manual of
Surgery
Bailey & Love’s short practice of
surgery
Clinical surgery ( A.cuschieri).